Prescribing Advice for GPs

An NHS Prescribing Advisers' Blog

GSK sued by investors

GlaxoSmithKline (GSK), the manufacturer of rosiglitazone (Avandia®), is facing a lawsuit in America claiming that it misled investors and withheld drug safety information.

PharmaTimes provides more details about the lawsuit. In particular this report notes that GSK performed their own meta-analysis that was submitted to the Food and Drugs Administration (FDA) in August 2006 that shows an increased risk of heart attacks. It is claimed that this information was "never adequately disclosed to the investing public". This claim may relate to the previously reported interim-analysis of the RECORD study.

Action: Media coverage of this lawsuit is likely to encourage patients taking rosiglitazone to consult about the risks and benefits of continued treatment.

Share 'GSK sued by investors' on Email Share 'GSK sued by investors' on Delicious Share 'GSK sued by investors' on Digg Share 'GSK sued by investors' on Facebook Share 'GSK sued by investors' on Google+ Share 'GSK sued by investors' on reddit Share 'GSK sued by investors' on StumbleUpon Share 'GSK sued by investors' on Twitter

atomic-wealth

No Comments to “GSK sued by investors”

Leave a Comment

(required)

(required)


Prescribing Advice for GPs is powered by WordPress.
Subscribe for Free to our RSS or Atom Feeds for New Entries.
Akismet has protected Prescribing Advice for GPs from 789,615 spam comments.

atomic-wealth
fond-illness
summer